EGFR and breast carcinoma: Similarly, Bhattacharyya et al., using [89Zr]Zr-DFO-panitumumab, demonstrated a strong correlation (r2 = 0.857) between tumor uptake and EGFR expression in mice carrying breast cancer xenografts, with notably elevated lymph node activity [146].